Lawsuit Update Center
If you were exposed to Paraquat and later diagnosed with Parkinson’s disease, you may have the right to pursue a lawsuit and seek financial compensation. Our Paraquat lawyers are reviewing new Parkinson’s disease claims from across the country.
This page explains the current Paraquat settlement process, the federal multidistrict litigation, the evidence connecting Paraquat exposure to Parkinson’s disease, possible settlement amounts, and what you need to prove to bring a claim.
A confidential settlement process is now underway for many federal plaintiffs, while cases involving people who rejected their settlement offers continue to move through discovery.
Were You Exposed to Paraquat?
A strong claim usually involves a confirmed Parkinson’s disease diagnosis and regular occupational exposure through mixing, loading, spraying, equipment cleaning, crop work, or employment near Paraquat applications. You do not need every exposure record before calling. Call us at 888-322-3010 or request a free case review.
Paraquat Lawsuit Status at a Glance
- Federal litigation: MDL No. 3004 remains pending in the Southern District of Illinois.
- Pending cases: The July 1, 2026 JPML report listed 6,665 pending federal actions.
- Settlement: Many plaintiffs have received confidential settlement offers pursuant to the 2025 Master Settlement Agreement.
- Opt-out cases: Plaintiffs who rejected offers may continue litigating, but the court is requiring selected claims to undergo detailed exposure and medical discovery.
- Public payout information: Individual settlement amounts and the settlement matrix have not been released publicly.
Page Navigation
Paraquat Lawsuit Updates
August 3, 2026: Settlement Administration Continues While Opt-Out Cases Move Forward
The federal Paraquat litigation remains active while settlement offers are processed and selected opt-out cases undergo discovery. The official July 1 JPML report listed 6,665 pending actions and 8,484 actions filed over the life of the MDL.
The court has confirmed that many plaintiffs accepted settlement offers, while others rejected them. Judge Nancy Rosenstengel ordered selected opt-out plaintiffs to complete detailed fact sheets, sit for depositions, and produce proof concerning Paraquat use, applicator licensing, protective equipment, Parkinson’s diagnosis, symptoms, and family medical history.
This tells us exactly what will separate strong claims from weak ones. A plaintiff who can document years of direct Paraquat exposure and a clear Parkinson’s diagnosis has a better chance than someone relying on a vague memory of working somewhere pesticides were used.
July 2026: Supreme Court Pesticide Ruling Creates a New Defense Issue
The Paraquat defendants are expected to rely heavily on the Supreme Court’s June decision in Monsanto v. Durnell. That case involved Roundup, not Paraquat, but the Court held that federal pesticide law barred a state-law labeling claim where EPA had not required the warning sought by the plaintiff.
Syngenta will argue that the same reasoning applies to Paraquat failure-to-warn claims. Plaintiffs will respond that Paraquat cases involve a different chemical, different regulatory history, different product representations, and claims that extend beyond the wording of the EPA-approved label.
This ruling is a serious defense weapon. It does not automatically erase every Paraquat lawsuit, but lawyers now have to evaluate preemption, design defect, negligence, concealment, and misrepresentation claims with much greater care.
June 2026: Syngenta Stops Producing Paraquat
Syngenta ended global production of Paraquat at its United Kingdom manufacturing facility. The company said the decision was based on competition from generic manufacturers and denied that it reflected any concession about Parkinson’s disease or product safety.
The announcement is still significant. Syngenta introduced Paraquat through a predecessor company and defended the product for decades. Its exit does not remove Paraquat from the market because other manufacturers can continue selling generic products, but it closes a major chapter in the product’s history.
May 26, 2026: Vermont Becomes First State to Ban Paraquat
Vermont enacted Act 112, becoming the first state to prohibit the sale and use of Paraquat. The general ban takes effect November 1, 2026, with limited transition provisions for certain fruit growers.
A state ban is not proof of legal causation in an individual lawsuit. But plaintiffs will point to Vermont’s action as evidence that concerns about Paraquat exposure have moved beyond academic debate and into public policy.
Current Paraquat Settlement Status
A 2025 Master Settlement Agreement now governs settlement offers for many plaintiffs in the federal litigation. The settlement terms, payment matrix, total funding, and individual offers remain confidential.
The court’s orders show that eligible cases were assigned settlement tiers and individual offers. Many plaintiffs accepted. Others opted out, and a smaller group had not made a final decision when the court reviewed the process.
The settlement does not resolve every Paraquat claim. Plaintiffs who did not qualify or declined their offers may continue litigating, subject to court orders requiring proof of exposure, diagnosis, and damages.
Have Paraquat Settlement Checks Been Issued?
Settlement administration is underway, but there is no public payment ledger showing which plaintiffs have been paid, when checks were issued, or the amount of individual payments. Processing can take time because administrators must confirm eligibility, calculate awards, address medical liens, obtain releases, and resolve probate issues in claims involving deceased plaintiffs.
Your lawyer should be the source of information about your individual offer and payment status. Online estimates cannot tell you what tier you were assigned or what deductions may apply.
About Paraquat
Paraquat, also known as Paraquat dichloride, is a powerful herbicide used to kill weeds and grass. It has been sold under brand names including Gramoxone and is commonly used in commercial agriculture.
EPA classifies Paraquat as a restricted-use pesticide. It cannot legally be purchased or applied by the general public. Its use is limited to certified applicators who must complete specialized training and follow strict handling requirements.
Paraquat became increasingly important to growers as weeds developed resistance to other herbicides. It can be used before planting, between crop rows, in orchards, and to dry certain crops before harvest.
The chemical is acutely toxic. Swallowing even a relatively small amount can be fatal. The Parkinson’s disease lawsuits focus on a different issue: whether repeated exposure through application, inhalation, skin contact, equipment cleaning, or agricultural work can cause long-term neurological injury.
Why Plaintiffs Link Paraquat to Parkinson’s Disease
Parkinson’s disease is a progressive neurological disorder. It damages dopamine-producing neurons in an area of the brain that helps control movement. Symptoms can include tremors, stiffness, slowed movement, balance problems, speech changes, sleep disruption, cognitive decline, and loss of independence.
For years, researchers have studied whether Paraquat exposure increases the risk of Parkinson’s disease. Several epidemiological and laboratory studies have reported an association, particularly among agricultural workers and people with repeated occupational exposure.
Plaintiffs argue that Paraquat creates oxidative stress and damages the same types of brain cells that deteriorate in Parkinson’s disease. They also point to animal research, occupational studies, internal corporate documents, and studies involving people living near agricultural applications.
Syngenta disputes causation. The company argues that the research is inconsistent, that some studies found no association, and that no reliable scientific method can prove Paraquat caused Parkinson’s disease in a particular person.
That scientific fight is the center of the litigation. A diagnosis alone is not enough. Plaintiffs must also prove meaningful exposure and present expert testimony connecting that exposure to the disease.
The Paraquat Papers
Internal company documents have fueled the plaintiffs’ allegations that Paraquat manufacturers understood more about the product’s risks than they disclosed publicly.
Former Syngenta toxicologist Jon Heylings raised concerns about the amount of the vomiting agent PP796 used in Gramoxone. Other reporting has focused on internal research, corporate responses to independent Parkinson’s studies, and efforts to influence the public discussion about Paraquat safety.
Those documents do not replace medical causation evidence. But they may support failure-to-warn, negligence, concealment, and punitive damages claims, as well as corporate knowledge claims, where those causes of action remain legally available.
Legal Allegations in Paraquat Lawsuits
Every Paraquat case has its own exposure and medical history. The lawsuits generally bring several related claims:
Failure to Warn
Plaintiffs allege that manufacturers failed to adequately warn applicators and agricultural workers about the risk of Parkinson’s disease. The scope of these claims is now under heavier scrutiny after the Supreme Court’s 2026 pesticide-labeling decision.
Defective Design
The lawsuits claim Paraquat was unreasonably dangerous and that the manufacturers should have adopted safer formulations, handling systems, or other protective measures.
Negligence
Plaintiffs contend that the defendants failed to adequately test the product, investigate neurological risks, communicate dangers, and protect foreseeable users.
Concealment and Misrepresentation
Some claims allege that manufacturers downplayed unfavorable research, promoted reassuring safety messages, and withheld information that would have changed how workers handled Paraquat.
Who May Qualify for a Paraquat Lawsuit?
The strongest Paraquat cases usually involve direct, repeated exposure and a formal Parkinson’s disease diagnosis.
Our lawyers are particularly interested in claims involving:
- Farmers, farmhands, crop workers, and commercial pesticide applicators.
- People who mixed, loaded, sprayed, transferred, or cleaned equipment used with Paraquat.
- Workers who handled Gramoxone or another identifiable Paraquat product over a substantial period.
- A diagnosis of Parkinson’s disease or qualifying parkinsonism after the exposure period.
- Medical records and work history consistent with the claimed exposure and diagnosis.
Claims based only on living near fields can be harder to prove because the plaintiff must establish that Paraquat was actually applied nearby, that exposure occurred, and that the dose and duration were sufficient to contribute to Parkinson’s disease. EPA’s continuing review of volatilization could become relevant to these claims.
Do not worry if you cannot remember the exact product name or dates. Former employers, applicator records, purchase records, crop histories, coworkers, photographs, and agricultural records may help reconstruct your exposure.
Potential Paraquat Settlement Amounts
Individual Paraquat settlement amounts have not been made public. The settlement matrix, funding totals, tiers, and offers remain confidential. You should be skeptical of websites listing an average Paraquat settlement. Those numbers are predictions, not reported results.
We still believe strong Paraquat cases can have substantial six-figure value. The best cases may be worth more. But weaker exposure claims, disputed diagnoses, short exposure periods, and significant alternative causes can reduce value sharply.
What Will Drive an Individual Paraquat Payout?
- Exposure proof: Years of direct mixing, loading, spraying, or equipment cleaning are stronger than vague or occasional exposure.
- Product identification: Records or witnesses connecting the plaintiff to Gramoxone or another Paraquat product improve the case.
- Diagnosis: A confirmed Parkinson’s disease diagnosis from a neurologist is stronger than nonspecific tremor symptoms.
- Disease severity: Mobility loss, cognitive decline, inability to work, falls, hospitalization, and full-time care increase damages.
- Age: A younger plaintiff may face more years of disability, treatment, lost income, and lost independence.
- Alternative causes: Family history, other chemical exposures, certain medications, and competing neurological conditions can affect causation.
- Legal posture: Settlement eligibility, state law, preemption defenses, and available claims may significantly affect value.
Compensation Available in a Paraquat Lawsuit
A successful Paraquat lawsuit may seek compensation for:
- Past and future medical expenses.
- Medication, physical therapy, mobility devices, and home modifications.
- Home health care, nursing assistance, and future custodial care.
- Lost income and reduced earning capacity.
- Pain, suffering, disability, and loss of independence.
- Loss of consortium suffered by a spouse.
- Punitive damages where the facts and governing law permit them.
Evidence That Helps a Paraquat Claim
The current opt-out discovery orders show what the court and defendants want to see. Start collecting what you can, but do not delay contacting a lawyer because some records are missing.
- Neurology records confirming Parkinson’s disease and the date of diagnosis.
- Employment records showing farm, agricultural, groundskeeping, or pesticide work.
- Applicator licenses, training records, purchase records, invoices, or product receipts.
- Names of employers, supervisors, coworkers, farms, crops, and locations.
- Approximate years, frequency, and method of Paraquat use.
- Information about gloves, masks, respirators, protective clothing, spills, leaks, and equipment cleaning.
- Photographs of product containers, equipment, storage areas, or work locations.
- Records showing lost work, disability, home care, medical costs, and the effect of Parkinson’s disease on daily life.
Deadline for Filing a Paraquat Lawsuit
Every state has a statute of limitations. In many states, the deadline may be two or three years, but the starting date can depend on when you were diagnosed, when you learned Paraquat could be connected to Parkinson’s disease, where the exposure occurred, and which defendant you are suing.
The settlement process can also create practical deadlines that are separate from the statute of limitations. Waiting can make it harder to locate product records, employers, witnesses, and medical evidence.
Do not assume your case is too old. But do not treat the filing period as unlimited. A lawyer needs to review your exposure and diagnosis dates before giving you a reliable deadline.
Paraquat Lawsuit FAQ
Contact Our Paraquat Lawyers
If you used or were regularly exposed to Paraquat and have been formally diagnosed with Parkinson’s disease, call us at 888-322-3010 or request a free case review.
